The main focus in health has been on the life science, MedTech and diagnostics businesses spinning out from the research department of UK Universities, as well as digital health providers in Africa.

Baobab Circle – a start-up established by a team of clinicians, doctors and software designers based in East Africa and Europe, has created a mobile App to provide health education and personalised chronic disease management to individuals in Sub-Saharan Africa.

Cliniva – is establishing a network of digitally connected health clinics in Kenya staffed only by nurses.

Cotton Mouton Diagnostics – a spin-out from the University of Cardiff, is developing a low cost diagnostic device for laboratory and doctor’s surgery applications, based upon magneto-optical technology, for use in the early detection of endotoxins and septicemia, the latter currently one of the world’s biggest killers on account of late detection.

Ilara Health – provides inexpensive diagnostic equipment to health clinics in Africa

Micrima – a spin-out from the University of Bristol engineering department, has developed a breast scanning device using microwave imaging technology which is much safer, more accurate and cheaper than current X-ray technologies and which will be able to distinguish between cysts and tumours and malignant and benign tumours.

Momentum Bioscience – has invented a blood test that can show within eighteen hours whether a patient who appears to be very poorly is suffering from septicaemia or not, which compares to the five days that it takes currently to rule out such a finding which will have the benefit of significantly reducing the unnecessary prescription of antibiotics.

Orbit – has developed an innovative peptide display engine to identify peptide combinations for use in drug development.

OrganOx – a spin-out from Oxford University, has developed a portable medical device for keeping livers “alive” for up to twenty four hours ahead of organ transplant at normal body temperature whilst generating real time data on its status. Superior to the current cold state static approach, the device will increase the quality and supply of organs available for transplantation of which there is a severe shortage.

Orthoson – a sister company to Oxsonics, seeks to use ultrasound and polymer bubbles to repair damaged spinal cartilage.

Oxford Brain Diagnostics – has developed a way to interpret MRI scans for early signs of Alzheimer’s Disease.

OxSonics – a spin-out from the University of Oxford’s Institute of Biomedical Engineering, is commercialising a technique which uses ultrasound to cause polymer bubbles to expand and collapse for the more effective delivery of chemotherapy drugs into solid tumours making it possible to reach cancer cells that lie farthest from blood vessels; and through a sister company is using the same technology to provide a minimally-invasive alternative to spinal fusion for those with severe back problems.

T-Cyper – is a spin-out from Orbit Discovery aiming to develop T.Cell Receptor based drugs for the treatment of cancer.